Recombinant Human SLC22A5 Protein, N-His-SUMO

Description of Recombinant Human SLC22A5 Protein, N-His-SUMO

Introduction

Recombinant Human SLC22A5 Protein, also known as Organic Cation Transporter 2 (OCT2), is a transmembrane protein that is encoded by the SLC22A5 gene. It belongs to the solute carrier family of proteins and plays a crucial role in the transportation of organic cations across cell membranes. This protein has been extensively studied for its structure, activity, and potential applications in various fields of research.

Structure of Recombinant Human SLC22A5 Protein

The human SLC22A5 gene is located on chromosome 5 and consists of 11 exons, which encode for a protein of 555 amino acids. The protein has a predicted molecular weight of 61.5 kDa and contains 12 transmembrane domains, with both the N- and C-termini located in the cytoplasm. The structure of the protein is highly conserved among different species, with a sequence identity of 98% between human and mouse OCT2.

Activity of Recombinant Human SLC22A5 Protein

Recombinant Human SLC22A5 Protein is primarily involved in the transport of organic cations, including endogenous molecules such as dopamine, serotonin, and choline, as well as exogenous compounds like metformin and cimetidine. This transport is facilitated by the electrochemical gradient across the cell membrane, with the protein acting as a secondary active transporter.

Studies have shown that OCT2 is highly expressed in the kidney, liver, and brain, with lower levels in other tissues such as the heart, lung, and skeletal muscle. It is predominantly localized on the basolateral membrane of epithelial cells, where it plays a crucial role in the uptake and elimination of organic cations from the body.

Applications of Recombinant Human SLC22A5 Protein

Recombinant Human SLC22A5 Protein has been extensively studied for its potential applications in various fields, including pharmacology, toxicology, and oncology.

In pharmacology, OCT2 is a major determinant of the renal clearance of many drugs, making it a crucial target for drug-drug interactions. Studies have shown that genetic variations in the SLC22A5 gene can affect the activity of OCT2 and alter the pharmacokinetics of drugs, leading to adverse drug reactions. Therefore, recombinant OCT2 protein is used in drug screening assays to identify potential drug interactions and improve drug safety.

In toxicology, OCT2 plays a vital role in the elimination of environmental toxins and drugs from the body. The protein is highly expressed in the kidney, which is the primary organ responsible for the excretion of toxic compounds. Recombinant Human SLC22A5 Protein is used in toxicology studies to understand the mechanisms of drug-induced nephrotoxicity and to identify potential nephrotoxic compounds.

In oncology, OCT2 has been identified as a potential therapeutic target for the treatment of cancer. Studies have shown that OCT2 is overexpressed in certain types of cancer, including breast, prostate, and pancreatic cancer. Recombinant Human SLC22A5 Protein is used in cancer research to study the role of OCT2 in tumor growth and to develop novel therapies that target OCT2.

Conclusion

Recombinant Human SLC22A5 Protein, also known as Organic Cation Transporter 2, is a transmembrane protein that plays a crucial role in the transport of organic cations across cell membranes. It is highly conserved among different species and is predominantly expressed in the kidney, liver, and brain. The protein has various applications in pharmacology, toxicology, and oncology, making it a valuable tool for research in these fields. Further studies on the structure and activity of OCT2 will provide a better understanding of its role in health and disease and may lead to the development of new treatments for various disorders.